Goldsborough, E., Osuji, N., & Blaha, M. J. (2022). Assessment of Cardiovascular Disease Risk: A 2022 Update. Endocrinology and metabolism clinics of North America, 51(3), 483. https://doi.org/10.1016/j.ecl.2022.02.005
Chicago Style (17th ed.) CitationGoldsborough, Earl, Ngozi Osuji, and Michael J. Blaha. "Assessment of Cardiovascular Disease Risk: A 2022 Update." Endocrinology and Metabolism Clinics of North America 51, no. 3 (2022): 483. https://doi.org/10.1016/j.ecl.2022.02.005.
MLA (9th ed.) CitationGoldsborough, Earl, et al. "Assessment of Cardiovascular Disease Risk: A 2022 Update." Endocrinology and Metabolism Clinics of North America, vol. 51, no. 3, 2022, p. 483, https://doi.org/10.1016/j.ecl.2022.02.005.
Warning: These citations may not always be 100% accurate.